Results 61 to 70 of about 7,183 (232)

The safety of enoxaparine use in elderly with acute myocardial infarction [PDF]

open access: yes, 2007
Background/Aim. Enoxaparin (ENOX), the lowmolecular- weight heparin, used in acute myocardial infarction (AMI) could lead to hemorrhage. The aim of this study was to determine whether bleeding was more often in AMI patients older than 65 or 75 years who ...
Despotović Nebojša   +4 more
core   +1 more source

Efficacy and safety of tenecteplase for acute ischemic stroke within an extended treatment window: a systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials [PDF]

open access: yesJournal of Neurocritical Care
Background In acute ischemic stroke (AIS), the treatment window for thrombolytics is 4.5 hours from symptom onset. Tenecteplase, a modified tissue plasminogen activator, may be effective over an extended treatment window (4.5–24 hours).
Hesham Kelani   +15 more
doaj   +1 more source

Review of Protocols Used in Ultrasound Thrombolysis [PDF]

open access: yes, 2017
Objectives: This paper focuses on the review of protocols used in thrombolysis studies with ultrasound. Materials and methods: Data from peer-review articles were acquired.
Damianou, C.   +2 more
core   +1 more source

Tenecteplase Treatment and Thrombus Characteristics Associated With Early Reperfusion: An EXTEND-IA TNK Trials Analysis [PDF]

open access: bronze, 2023
Vignan Yogendrakumar   +33 more
openalex   +1 more source

Efficacy and Safety of Nerinetide in Acute Ischemic Stroke Patients: A Systematic Review, Meta‐Analysis and Meta Regression

open access: yesBrain and Behavior, Volume 15, Issue 11, November 2025.
Nerinetide modestly reduced mortality in acute ischemic stroke (RR = 0.86; p = 0.05) without improving functional recovery (mRS, Barthel Index, infarct volume). Safety was comparable to placebo. Further large RCTs are needed to clarify its role and interaction with reperfusion therapies.
Laiba Khurram   +14 more
wiley   +1 more source

Thrombolytic therapy for patients with acute ischemic stroke: systematic review and network meta-analysis of randomized trials

open access: yesFrontiers in Neurology
ObjectiveTo systematically compare the benefits and risks of all thrombolytic agents (tenecteplase, reteplase, and alteplase) at different doses for thrombolytic therapy in patients with acute ischemic stroke (AIS).BackgroundAlteplase is the cornerstone ...
Li-Chao-Yue Sun   +8 more
doaj   +1 more source

Influence of the double antiplatelet therapy on patency of the infarct related artery after acute myocardial infarction with ST-segment elevation [PDF]

open access: yes, 2007
Background/Aim. Most patients with acute myocardial infarction with ST-segment elevation (STEMI) are still treated with pharmacological reperfusion, which is not always successful.
Apostolović Svetlana   +9 more
core   +1 more source

To Bridge or Not to Bridge? A Meta‐Analysis of Intravenous Thrombolysis Before Thrombectomy in Large Ischemic Core Strokes

open access: yesBrain and Behavior, Volume 15, Issue 11, November 2025.
Based on the included 7 studies, in patients with large ischemic core infarcts, IVT before EVT offers no significant clinical or procedural benefit compared to EVT alone. ABSTRACT Background Endovascular thrombectomy (EVT) is the standard treatment for acute ischemic stroke (AIS) caused by large vessel occlusion (LVO).
Abdelrahman Elgharabawi   +12 more
wiley   +1 more source

Successful use of intra venous tenecteplase for acute ischemic stroke in pregnancy

open access: yeseNeurologicalSci
Intravenous thrombolysis (IVT) with tenecteplase or alteplase is the standard of care in, patients with Acute Ischemic Stroke (AIS) presenting within 3–4.5 h. However here, are no established guidelines for such treatment during pregnancy.
Balamurugan Namasivayam   +4 more
doaj   +1 more source

Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: results of a randomized, double-blind, parallel-group, multicenter, European study (SMILE-4) [PDF]

open access: yes, 2012
BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) are largely employed for treating patients with left ventricular dysfunction (LVD), but their efficacy may be negatively affected by concomitant administration of acetylsalicylic acid (ASA),
Claudio Borghi   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy